Evidence map›Paper›PMID 30719331›Full record

ArticleEuropean journal of microbiology & immunology2018

405 nm and 450 nm Photoinactivation of

K Hoenes, M Hess, P Vatter, B Spellerberg, M Hessling

Open access · diamondAbstract read
In one paragraph

Article in European journal of microbiology & immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Riboflavin- and chlorophyllin-based antimicrobial photoinactivation ofFrontiers in cellular and infection microbiology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. TheFrontiers in microbiology · 2020
    Article
  12. Antimicrobial Effect of Visible Light-Photoinactivation ofAntibiotics (Basel, Switzerland) · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K HoenesUlm University of Applied Sciences, Albert-Einstein-Allee 55, D 89081 Ulm, Germany.
M HessUlm University of Applied Sciences, Albert-Einstein-Allee 55, D 89081 Ulm, Germany.
P VatterUlm University of Applied Sciences, Albert-Einstein-Allee 55, D 89081 Ulm, Germany.
B SpellerbergInstitute of Medical Microbiology and Hygiene, University of Ulm, Ulm, Germany.
M HesslingUlm University of Applied Sciences, Albert-Einstein-Allee 55, D 89081 Ulm, Germany.
Technische Hochschule Ulm · DEUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photoinactivation of bacteria with visible light has been reported in numerous studies. Radiation around 405 nm is absorbed by endogenous porphyrins and generates reactive oxygen species that destroy bacteria from within. Blue light in the spectral range of 450-470 nm also exhibits an antibacterial effect, but it is weaker than 405 nm radiation, and the photosensitizers involved have not been clarified yet, even though flavins and porphyrins are possible candidates. There are significantly fewer photoinactivation studies on fungi. To test if visible light can inactivate fungi and to elucidate the mechanisms involved, the model organism

Indexed as

405 nm irradiation450 nm irradiationdisinfectionflavinphotoinactivationporphyrinSaccharomyces cerevisiae

Identifiers

PMID30719331
PMCPMC6348701
OpenAlexW2904336493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.